Adverse reactions and amphotericin B

2010, Number 92

Rev Enfer Infec Pediatr 2010; 23.24 (92)

Vázquez TO, Campos RT

Language: Spanish
References: 8
Page: 112-113
PDF size: 150.14 Kb.

Text Extraction

No abstract

REFERENCES

Coria LJJ, Vázquez TO, Rosibell CM, Campos RT. Usos clínicos de la anfotericina B 1a parte. Acta Pediatr Mex 1999;20:304-9.
Coria LJJ, Vázquez TO, Rosibell CM, Campos RT. Usos clínicos de la anfotericina B 2a parte. Acta Pediatr Mex 2000;21:11-5.
Vázquez-Tsuji O. Guía para el tratamiento de las enfermedades parasitarias. Primera Edición. Editorial Trillas/Universidad La Salle. ISBN 978-607-17-0079-7. México, 2009. p. 210-40.
Antoniskis D, Larsen RA. Acute, rapidly progresive renal failure with simultaneous use of amphotericin B and pentamidine. Antimicrob Agents Chemother 1990;34:470-2.
Meunier-Carpentier F, Cruciani M, Klastersky J. Oral prophlaxis with miconazole or ketoconazole of invasive fangal disease in neurotropenic cancer patients. Eur J Cancer Clin Oncol 1983;19:43-8.
Bellmann R. Clinical pharmacokinetics of systemically administered antimycotics. Current Clinical Pharmacology 2007;2:37-58.
Pennick GJ, McGough DA, Barchiesi F Rinaldi MG. Concomitant therapy with amphotericin B and itraconazole: Does this combination affect the serum concentracion of itraconazole? Intersci Conf Antimicrob Agents Chemother 1994;34:39.
Persat F, Schwartzbrod PE, Troncy J, Timour Q, Maul A, Piens Ma, Picot S. Abnormalities in live enzymes during simultaneous therapy with itraconazole and amphotericin B in leukaemic patients. J Antimicrob Chemother 2000;45:928-30.